| HGNC Family | Non-coding RNAs |
| Name | microRNA 6883 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nRecent studies have revealed that miR-6883-5p—an intronic microRNA encoded within the clock gene PER1—plays a critical role in colorectal cancer by targeting the 3′ untranslated regions of CDK4 and CDK6 mRNAs. This targeting results in the downregulation of these key cell-cycle regulators, contributing to a significant inhibition of tumor cell proliferation."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n\nEctopic expression of miR-6883-5p in colorectal cancer cells induces a robust G0-G1 phase cell-cycle arrest and triggers apoptosis. Although CDK4/6 downregulation is an important mechanism underlying these anti-proliferative effects, additional pathways are likely involved in mediating its full spectrum of tumor suppressor capabilities."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n\nMoreover, miR-6883-5p demonstrates a synergistic effect when combined with conventional chemotherapy—specifically, it enhances the efficacy of irinotecan and re-sensitizes mutant p53-expressing cell lines that are resistant to 5-fluorouracil. These findings underscore the promise of miR-6883-5p as a candidate for developing miRNA-based theranostic strategies to improve colorectal cancer management."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Amriti R Lulla, Michael J Slifker, Yan Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-6883 Family miRNAs Target CDK4/6 to Induce G"}, {"type": "a", "children": [{"type": "t", "text": "sub"}], "href": "sub"}, {"type": "t", "text": "1"}, {"type": "a", "children": [{"type": "t", "text": "/sub"}], "href": "/sub"}, {"type": "t", "text": " Phase Cell-Cycle Arrest in Colon Cancer Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-17-1767"}], "href": "https://doi.org/10.1158/0008-5472.CAN-17-1767"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29061672"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29061672"}]}]}]}
|
| Synonyms | HSA-MIR-6883 |
| NCBI Gene ID | 102465532 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR6883 has 0 functional associations with biological entities spanning 0 categories () extracted from 0 datasets.
Click the + buttons to view associations for MIR6883 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary |
|---|